103 related articles for article (PubMed ID: 15578042)
1. Stable, long-term label opens doors for gene therapy.
Lundberg C
Gene Ther; 2005 Feb; 12(3):195. PubMed ID: 15578042
[No Abstract] [Full Text] [Related]
2. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
3. Politically correct gene therapy? A "clean environment" improves gene delivery to the brain!
Lowenstein PR; Thomas CE; Castro MG
Gene Ther; 1999 Apr; 6(4):463-4. PubMed ID: 10476205
[No Abstract] [Full Text] [Related]
4. Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system.
Snyder EY; Park KI; Flax JD; Liu S; Rosario CM; Yandava BD; Aurora S
Adv Neurol; 1997; 72():121-32. PubMed ID: 8993691
[No Abstract] [Full Text] [Related]
5. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy.
Capowski EE; Schneider BL; Ebert AD; Seehus CR; Szulc J; Zufferey R; Aebischer P; Svendsen CN
J Neurosci Methods; 2007 Jul; 163(2):338-49. PubMed ID: 17397931
[TBL] [Abstract][Full Text] [Related]
7. Ephemeral gene medicine for the brain.
Mallet J; Serguera C
Nat Biotechnol; 2000 Sep; 18(9):930-1. PubMed ID: 10973208
[No Abstract] [Full Text] [Related]
8. Sendai virus for gene therapy and vaccination.
Griesenbach U; Inoue M; Hasegawa M; Alton EW
Curr Opin Mol Ther; 2005 Aug; 7(4):346-52. PubMed ID: 16121700
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
Nanou A; Azzouz M
Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
12. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
[TBL] [Abstract][Full Text] [Related]
13. [Application of non-invasive gene therapy for central nervous system diseases].
Fu AL; Zhou RM; Zhao BQ
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):307-9. PubMed ID: 21416952
[No Abstract] [Full Text] [Related]
14. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
15. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of in vivo neuroprotection by BclX(L) and GDNF co-expression depends on post-lesion time in deafferentiated CNS neurons.
Shevtsova Z; Malik I; Garrido M; Schöll U; Bähr M; Kügler S
Gene Ther; 2006 Nov; 13(22):1569-78. PubMed ID: 16838029
[TBL] [Abstract][Full Text] [Related]
17. Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors.
McKay T; Patel M; Pickles RJ; Johnson LG; Olsen JC
Gene Ther; 2006 Apr; 13(8):715-24. PubMed ID: 16397505
[TBL] [Abstract][Full Text] [Related]
18. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
Kremer KL; Dunning KR; Parsons DW; Anson DS
J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors for use in the central nervous system.
Jakobsson J; Lundberg C
Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676
[TBL] [Abstract][Full Text] [Related]
20. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy.
Scherr M; Battmer K; Schultheis B; Ganser A; Eder M
Gene Ther; 2005 Jan; 12(1):12-21. PubMed ID: 15602589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
